Events

Please share any pipeline additions and changes that you are aware of by 22 July 2019. Download and use this form to provide updates. The latest pipeline update (as of July 1, 2018), can be found as a manuscript (Theuretzbacher et al. Lancet ID 2018), and as a set of summary tables. Contact Sarah Paulin (paulins@who.int).

This is an open session hosted by the National Academy of Sciences, Engineering, and Medicine.  The 1.5-day public workshop to will be held on July 24-25, 2019 in Washington, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in […]

Keynote lecture given by Kevin Outterson, Executive Director of CARB-X. Additional details forthcoming.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences, Uppsala University, Sweden), will discuss: Population PK modelling to characterize drug exposure and variability PKPD-modelling […]

The ASM/ECSMID Conference on Drug Development returns to Boston, Massachusetts for 2019. Check back soon for program details. Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of […]

Sponsored by the Harvard Microbial Sciences Initiative and the Boston Area Antimicrobial Research Network Drinks, hors d'oeuvres, and exclusive private access to the Harvard Museum of Natural History https://hmnh.harvard.edu/. This is a chance to unwind with fellow attendees at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, and meet those […]

Online registration will open in spring 2019 - Check back soon for details.

This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health. Held at the University of Cambridge, an international hub for legal and scientific expertise, we hope […]

We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th, 2019 in Boston, immediately following the conclusion of the ASM-ESCMID conference.  Additional details will follow.  Please save the date! This  will be an excellent networking event for CARB-X product developers, who will have […]

Additional Details Forthcoming.